86 related articles for article (PubMed ID: 16435569)
1. Correlation between quinolone uptakes by BCECs in vitro and brain-to-plasma concentration ratios in rats.
Liu XD; Wang DW; Xie L
Eur J Drug Metab Pharmacokinet; 2005; 30(4):249-54. PubMed ID: 16435569
[TBL] [Abstract][Full Text] [Related]
2. Transfection of brain capillary endothelial cells in primary culture with defined blood-brain barrier properties.
Burkhart A; Thomsen LB; Thomsen MS; Lichota J; Fazakas C; Krizbai I; Moos T
Fluids Barriers CNS; 2015 Aug; 12():19. PubMed ID: 26246240
[TBL] [Abstract][Full Text] [Related]
3. Establishment of coculture model of blood-brain barrier in vitro for nanoparticle's transcytosis and toxicity evaluation.
Lu W; Tan YZ; Jiang XG
Yao Xue Xue Bao; 2006 Apr; 41(4):296-304. PubMed ID: 16856472
[TBL] [Abstract][Full Text] [Related]
4. Efflux transport of a new quinolone antibacterial agent, HSR-903, across the blood-brain barrier.
Murata M; Tamai I; Kato H; Nagata O; Tsuji A
J Pharmacol Exp Ther; 1999 Jul; 290(1):51-7. PubMed ID: 10381759
[TBL] [Abstract][Full Text] [Related]
5. Limited distribution of new quinolone antibacterial agents into brain caused by multiple efflux transporters at the blood-brain barrier.
Tamai I; Yamashita J; Kido Y; Ohnari A; Sai Y; Shima Y; Naruhashi K; Koizumi S; Tsuji A
J Pharmacol Exp Ther; 2000 Oct; 295(1):146-52. PubMed ID: 10991972
[TBL] [Abstract][Full Text] [Related]
6. Brain capillary endothelial cells mediate iron transport into the brain by segregating iron from transferrin without the involvement of divalent metal transporter 1.
Moos T; Skjoerringe T; Gosk S; Morgan EH
J Neurochem; 2006 Sep; 98(6):1946-58. PubMed ID: 16879716
[TBL] [Abstract][Full Text] [Related]
7. LDLR-mediated peptide-22-conjugated nanoparticles for dual-targeting therapy of brain glioma.
Zhang B; Sun X; Mei H; Wang Y; Liao Z; Chen J; Zhang Q; Hu Y; Pang Z; Jiang X
Biomaterials; 2013 Dec; 34(36):9171-82. PubMed ID: 24008043
[TBL] [Abstract][Full Text] [Related]
8. Targeting anti-transferrin receptor antibody (OX26) and OX26-conjugated liposomes to brain capillary endothelial cells using in situ perfusion.
Gosk S; Vermehren C; Storm G; Moos T
J Cereb Blood Flow Metab; 2004 Nov; 24(11):1193-204. PubMed ID: 15545912
[TBL] [Abstract][Full Text] [Related]
9. Penetration of orally administered prulifloxacin into human lung tissue.
Concia E; Allegranzi B; Ciottoli GB; Orticelli G; Marchetti M; Dionisio P
Clin Pharmacokinet; 2005; 44(12):1287-94. PubMed ID: 16372826
[TBL] [Abstract][Full Text] [Related]
10. Effect of urinary excretion on the bladder tissue distribution of fluoroquinolones in rats.
Izawa S; Yamaoka M; Deguchi T
J Infect Chemother; 2015 Apr; 21(4):290-5. PubMed ID: 25640533
[TBL] [Abstract][Full Text] [Related]
11. A simple method for assessing free brain/free plasma ratios using an in vitro model of the blood brain barrier.
Culot M; Fabulas-da Costa A; Sevin E; Szorath E; Martinsson S; Renftel M; Hongmei Y; Cecchelli R; Lundquist S
PLoS One; 2013; 8(12):e80634. PubMed ID: 24312489
[TBL] [Abstract][Full Text] [Related]
12. [Phototoxicity studies of pazufloxacin mesilate, a novel parenteral quinolone antimicrobial agent--in vitro and in vivo studies].
Nagasawa M; Nakamura S; Miyazaki M; Nojima Y; Hayakawa H; Kawamura Y
Jpn J Antibiot; 2002 Jun; 55(3):259-69. PubMed ID: 12199110
[TBL] [Abstract][Full Text] [Related]
13. Active uptake of ulifloxacin from plasma to lung that controls its concentration in epithelial lining fluid.
Aoki M; Iguchi M; Hayashi H; Shibasaki S; Kurosawa T; Hayashi M
Biol Pharm Bull; 2009 Jun; 32(6):1095-100. PubMed ID: 19483322
[TBL] [Abstract][Full Text] [Related]
14. Blood-brain barrier transport of H1-antagonist ebastine and its metabolite carebastine.
Tamai I; Kido Y; Yamashita J; Sai Y; Tsuji A
J Drug Target; 2000; 8(6):383-93. PubMed ID: 11328664
[TBL] [Abstract][Full Text] [Related]
15. Dominant expression of androgen receptors and their functional regulation of organic anion transporter 3 in rat brain capillary endothelial cells; comparison of gene expression between the blood-brain and -retinal barriers.
Ohtsuki S; Tomi M; Hata T; Nagai Y; Hori S; Mori S; Hosoya K; Terasaki T
J Cell Physiol; 2005 Sep; 204(3):896-900. PubMed ID: 15795901
[TBL] [Abstract][Full Text] [Related]
16. Cationic albumin conjugated pegylated nanoparticle with its transcytosis ability and little toxicity against blood-brain barrier.
Lu W; Tan YZ; Hu KL; Jiang XG
Int J Pharm; 2005 May; 295(1-2):247-60. PubMed ID: 15848009
[TBL] [Abstract][Full Text] [Related]
17. Lactoferrin-modified poly(ethylene glycol)-grafted BSA nanoparticles as a dual-targeting carrier for treating brain gliomas.
Su Z; Xing L; Chen Y; Xu Y; Yang F; Zhang C; Ping Q; Xiao Y
Mol Pharm; 2014 Jun; 11(6):1823-34. PubMed ID: 24779677
[TBL] [Abstract][Full Text] [Related]
18. Contribution of glial cells and pericytes to the mRNA profiles of P-glycoprotein and multidrug resistance-associated proteins in an in vitro model of the blood-brain barrier.
Berezowski V; Landry C; Dehouck MP; Cecchelli R; Fenart L
Brain Res; 2004 Aug; 1018(1):1-9. PubMed ID: 15262198
[TBL] [Abstract][Full Text] [Related]
19. In vitro and in vivo investigation of glucose-mediated brain-targeting liposomes.
Qin Y; Fan W; Chen H; Yao N; Tang W; Tang J; Yuan W; Kuai R; Zhang Z; Wu Y; He Q
J Drug Target; 2010 Aug; 18(7):536-49. PubMed ID: 20132091
[TBL] [Abstract][Full Text] [Related]
20. Quantitative determination of sparfloxacin in rat plasma by liquid chromatography/tandem mass spectrometry.
Noh K; Kwon KI; Jeong TC; Kang W
Biomed Chromatogr; 2010 Nov; 24(11):1199-202. PubMed ID: 20737450
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
